Findings from this project are promising since people living with HD experience important gastrointestinal dysfuntion. With the BGRF support researchers uncovered a new potential direction of study for these disabling symptoms in HD. By targeting the inflammasome – which might potentially recover the community of microbes that inhabit the gut in HD – we can modify the gastrointestinal dysfunction present in this devastating disease.
